|
Match
|
Document |
Document Title |
|
|
6814979 |
Osmotic drug delivery system
Disclosed is an osmotic pharmaceutical delivery system comprising (a) a semi-permeable wall that maintains its integrity during pharmaceutical delivery and which has at least one passage...
|
|
|
6797704 |
Systemic delivery of compounds through non-invasive bladder administration
The present invention features methods of administering a therapeutic agent to a patient's lymph nodes by instillation of microparticles or nanoparticles comprising a biocompatible polymer and the...
|
|
|
6794367 |
Solid preparations for oral administration of drugs relating to genes
The invention provides solid preparations for oral administration of gene-related drugs comprising a core containing the gene-related drug with a coating which does not disintegrated in small...
|
|
|
6794464 |
Membrane or matrix for controlling the permeation rate of drugs
A membrane or matrix for controlling the permeation rate of a drug, where the membrane or matrix includes a siloxane-based elastomer composition which contains at least one elastomer and optionally...
|
|
|
6783773 |
Composition comprising amoxicillin and potassium clavulanate
Bacterial infections may be treated using a high dosage regimen of amoxicillin and potassium clavulanate. Preferably, the dosage is provided by a bilayer tablet.
|
|
|
6780436 |
Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound
The pharmaceutical formulation consists of a number of pellets that comprise an inert nucleus, a layer with the active ingredient, one or more intermediate layers that comprise at least a system of...
|
|
|
6770297 |
Controlled release delivery system of solid dosage form
This invention relates to a controlled release delivery system of solid dosage form with a plurality of controls on the release of the active ingredient or ingredients.
|
|
|
6753012 |
Method for coating pharmaceutical dosage forms
The invention provides a process for coating a branded pharmaceutical dosage form for the purpose of covering any embossed or printed matter or any colored coating by the application of an amount...
|
|
|
6753011 |
Combined diffusion/osmotic pumping drug delivery system
Delivery devices capable of delivering one or more active substances by diffusion through plural micropores in the membrane ( 4 ) or by osmotic pumping through one or more preformed passageways ( 5...
|
|
|
6747072 |
White ink for marking candy substrates
The present invention provides an ink composition for use in ink jet printing on food items, candy, particularly dark candy, such as chocolate, and to a method of forming printed images on such...
|
|
|
6746692 |
Modified release pharmaceutical formulation comprising amoxycillin
Bacterial infections may be treated using a high dosage regimen of amoxycillin and potassium clavulanate. Preferably, the dosage is provided by a bilayer tablet.
|
|
|
6743414 |
Inhalation administration of biophosphonates
The present invention relates to the treatment and prevention of bone diseases in humans, including osteoporosis in postmenopausal women, Paget's Disease and hypercalcemia, by administration of a...
|
|
|
6726927 |
Preparation of enteric pharmaceutical dosage forms for omerprazole and lansoprazole
The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such...
|
|
|
6727322 |
Amphiphilic networks, implantable immunoisolatory devices, and methods of preparation
The present invention provides high mechanical strength amphiphilic polymeric networks and implantable biological devices made therefrom that are capable of encasing and, thus, immunoisolating...
|
|
|
6723342 |
Edible coating composition
An edible, hardenable coating composition containing microcrystalline cellulose and carrageenan and at least one of a strengthening polymer, a plasticizer, a surface active agent or a combination...
|
|
|
6709681 |
Acidified nitrite as an antimicrobial agent
The present invention provides a dosage form for the treatment of bacterial, viral or fungal conditions which comprises, a pharmaceutically acceptable acidifying agent in an amount sufficient to...
|
|
|
6709678 |
Easy to swallow oral medicament composition
An oral composition which is adapted to be dispersed in an aqueous carrier substantially immediately prior to administration comprises a multiplicity of particles comprising an active substance,...
|
|
|
6706284 |
Bitterness-reduced oral pharmaceutical composition
The invention relates to an oral pharmaceutical composition which has excellent drug release-controlling ability in the mouth even 5 to 10 minutes after its administration and also has excellent...
|
|
|
6692768 |
Preparation method of drug-containing spherical fine particles
The present invention discloses an efficient preparation method of spherical fine particles containing a drug for an easily-swallowed, controlled-release preparation comprising the production of...
|
|
|
6676968 |
Release-regulating preparations comprising biphenyldiamine derivatives
A medicinal composition containing one or more compounds selected from the compounds represented by the following formula (I), salts of these compounds, solvates of these compounds and solvates of...
|
|
|
6669957 |
Galenic formulations fast disintegrating in the mouth and method for preparing same
The invention relates to pharmaceutical dosage forms with rapid disintegration in the mouth and to their process of preparation. These pharmaceutical dosage forms comprise at least one active...
|
|
|
6663896 |
Delayed release aspirin for vascular obstruction prophylaxis
A method and controlled release oral unit dosage form of acetylsalicylic acid (aspirin) delays the release of the drug until a predetermined time interval after ingestion. This enables the drug to...
|
|
|
6663893 |
Taste masking coating composition
There is provided a coating composition that masks the undesirable taste of a pharmaceutically active ingredient, i.e. drug or medicine, that is taken orally. The coating composition is comprised...
|
|
|
6660382 |
Process for manufacturing coated granules with masked taste and immediate release of the active principle
The invention concerns a method for making coated granules with masked taste and instant release of the active principle which consists in: first, mixing the constituents of a powder comprising at...
|
|
|
6649189 |
Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells
A hematopoietic growth factor delivery composition includes a hematopoietic growth factor, a liquid vehicle, a first biocompatible polymer and a second biocompatible polymer. The composition...
|
|
|
6642276 |
Controlled release macrolide pharmaceutical formulations
Disclosed is an oral controlled release macrolide pharmaceutical formulation. In a preferred embodiment, the formulation comprises a citrate salt of a preferred macrolide, clarithromycin. Also...
|
|
|
6638534 |
Preparation capable of releasing drug at target site in intestine
A preparation capable of releasing a medicinal substance at a targeted site in the intestine, wherein the preparation dose not releases medicinal substance in endogastri at all, but can quickly...
|
|
|
6632451 |
Delayed total release two pulse gastrointestinal drug delivery system
A two pulse gastrointestinal delivery system is provided. The system comprises a desired agent in combination with a swellable core material, the core being surrounded by an inner coat of a...
|
|
|
6632454 |
Multilayer pharmaceutical product for release in the colon
The invention relates to the use of a multilayer pharmaceutical product that substantially comprises a) a core containing a pharmaceutically active substance, b) an inner coating consisting of a...
|
|
|
6627188 |
Method of reducing bacterial enteropathogens in the crop of fowl subjected to feed withdrawal
A method for reducing bacterial enteropathogens in fowl subjected to feed withdrawal, involving withdrawing feed from fowl and orally administering to the fowl an effective amount of a cocktail...
|
|
|
6627224 |
Low dose entecavir formulation and use
Compositions containing a low dose of entecavir are administered on a daily basis to treat hepatitis B virus infection and/or co-infections. Formulations for the oral administration of a low dose...
|
|
|
6620431 |
Shellac film coatings providing release at selected pH and method
Film coatings for enteric and colonic release at selected pH are provided by selecting and/or formulating a shellac of a predetermined acid number. The method includes the selection of the acid...
|
|
|
6620617 |
Polymeric gene delivery system
A means for obtaining efficient introduction of exogenous genes into a patient, with long term expression of the gene, is disclosed. The gene, under control of an appropriate promoter for...
|
|
|
6613357 |
Osmotic device containing pseudoephedrine and an H1 antagonist
The present invention provides an osmotic device containing controlled release pseudoephedrine in the core in combination with a rapid release H1 antagonist in an external coat. A wide range of H1...
|
|
|
6613332 |
Oral administration of therapeutic proteins
An orally administrable therapeutic protein is provided by combining the therapeutic protein with a stabilizing agent in an aqueous solution. The solution is coated onto nonpareils and...
|
|
|
6599532 |
Osmotic device containing alprazolam and an antipsychotic agent
The present invention provides an osmotic device containing controlled release alprazolam in the core optionally in combination with an anti-psychotic agent, in a rapid release external coat. A...
|
|
|
6576258 |
Pharmaceutical formulation with controlled release of active substances
There is disclosed a method for stabilizing active substances that are unstable in acidic medium, unstable when stored for longer periods of time in the presence of water and at the same time...
|
|
|
6569460 |
Film-coated tablet for improved upper gastrointestinal tract safety
A novel oral dosage to be delivered to the stomach comprising a safe and effective amount of an active ingredient selected from the group consisting of emepronium bromidebromide, doxycycline, and...
|
|
|
6569461 |
Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
The instant invention provides methods and pharmaceutical compositions for inhibiting HMG-CoA reductase, as well as for treating and/or reducing the risk for diseases and conditions affected by...
|
|
|
6569462 |
Layering process for multiparticulate dosage form
The present invention relates to a new layering process, in particular to a process for the manufacture of multiparticulate solid oral dosage forms based on a dry spray layering technique...
|
|
|
6569463 |
Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions
The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one...
|
|
|
6562375 |
Stable pharmaceutical composition for oral use
The present invention is to provide a stable pharmaceutical composition for oral use and preparation thereof in which changes are prevented in drug release at stored even under the exposure to...
|
|
|
6558701 |
Multilayer tablet for administering a fixed combination of tramadol and diclofenac
A multilayer tablet for oral administration containing at least one Tramadol layer including Tramadol or a physiologically acceptable salt thereof; at least one diclofenac layer including...
|
|
|
6555136 |
Pharmaceutical dosage form for pulsatile delivery of methylphenidate
Novel pharmaceutical dosage forms provide for pulsatile delivery of methylphenidate, i.e., release encapsulated drug in spaced apart “pulses.” The dosage forms are comprised of first, second...
|
|
|
6548084 |
Controlled release compositions
A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxetine.
|
|
|
6544557 |
Effervescent tablet compositions
An effervescent sub-lingual type composition, optionally in tablet form, comprising at least one active ingredient, one ore more fruit acids, and one or more effervescing alkalis, wherein at least...
|
|
|
6531155 |
Granulates for cosmetic and pharmaceutical preparations
Granular materials are obtainable by pressing mixtures of at least one pulverulent, rheology-modifying, carboxyl-containing polymer as main component and at least one oil-soluble component.
|
|
|
6531152 |
Immediate release gastrointestinal drug delivery system
A gastrointestinal delivery system is provided. The system comprises a drug in combination with a swellable core material, the core being surrounded by a water-insoluble or relatively...
|
|
|
6528095 |
Anti-atherosclerotic and anti-thrombotic agent and the use thereof
A pharmaceutical agent for the prevention or treatment of any of the following conditions in mammals: atherosclerosis, thrombosis, unwanted high levels of free radicals, unwanted long fibrin clot...
|
|
|
6521255 |
Osmotic device containing ranitidine and a prokinetic agent
The present invention provides an osmotic device containing controlled release ranitidine in the core in combination with a prokinetic agent in a rapid release external coat. A wide range of...
|